BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 21294913)

  • 1. Adjuvant radiation therapy in metastatic lymph nodes from melanoma.
    Bibault JE; Dewas S; Mirabel X; Mortier L; Penel N; Vanseymortier L; Lartigau E
    Radiat Oncol; 2011 Feb; 6():12. PubMed ID: 21294913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.
    Strom T; Torres-Roca JF; Parekh A; Naghavi AO; Caudell JJ; Oliver DE; Messina JL; Khushalani NI; Zager JS; Sarnaik A; Mulé JJ; Trotti AM; Eschrich SA; Sondak VK; Harrison LB
    J Natl Compr Canc Netw; 2017 Apr; 15(4):473-482. PubMed ID: 28404758
    [No Abstract]   [Full Text] [Related]  

  • 3. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
    Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
    Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant irradiation for axillary metastases from malignant melanoma.
    Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma.
    Kim YJ; Song SY; Kim W; Jeong SY; Choi W; Je HU; Lee JS; Choi EK
    Anticancer Res; 2017 Aug; 37(8):4239-4246. PubMed ID: 28739713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
    Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI
    Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Locally recurrent and metastatic malignant melanoma. Long-term results and prognostic factors after percutaneous radiotherapy].
    Seegenschmiedt MH; Keilholz L; Pieritz A; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
    Strahlenther Onkol; 1999 Sep; 175(9):450-7. PubMed ID: 10518979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
    Henderson MA; Burmeister BH; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2015 Sep; 16(9):1049-1060. PubMed ID: 26206146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
    Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy.
    Hamming-Vrieze O; Balm AJ; Heemsbergen WD; Hooft van Huysduynen T; Rasch CR
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):795-800. PubMed ID: 19687401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
    Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation.
    Chang DT; Amdur RJ; Morris CG; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1051-5. PubMed ID: 16973303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
    Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
    Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
    Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
    Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
    Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical review of treatment outcomes and patterns of failure with adjuvant radiotherapy in node-positive malignant melanoma.
    Keenan LG; O'Sullivan S; Glynn A; Higgins M; Flavin A; Brennan S
    J Med Imaging Radiat Oncol; 2017 Apr; 61(2):258-262. PubMed ID: 27667733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy.
    Stevens G; Thompson JF; Firth I; O'Brien CJ; McCarthy WH; Quinn MJ
    Cancer; 2000 Jan; 88(1):88-94. PubMed ID: 10618610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiotherapy for palpable melanoma metastases to the groin: when to irradiate?
    Gojkovič-Horvat A; Jančar B; Blas M; Zumer B; Karner K; Hočevar M; Strojan P
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):310-6. PubMed ID: 22035662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control.
    Strom EA; Ross MI
    Ann Surg Oncol; 1995 Sep; 2(5):445-9. PubMed ID: 7496841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.